Advertisement

Halt Medical closes $15 million financing from American Capital to support commercialization of its newly FDA cleared Acessa System, an alternative to hysterectomy for women with uterine fibroids.

Halt logo

Halt Medical closed a $15 million funding round from American Capital, aimed at commercializing its FDA-cleared Acessa System for treating uterine fibroids.

The Las Vegas, Nev.-based device maker said its Acessa system allows physicians to deliver radiofrequency energy to uterine fibroids through a minimally invasive procedure.

Advertisement
Advertisement